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Abstract: Purpose: To establish a standardized reporting system of cholesteatoma, the ChOLE classifi-
cation has recently been introduced. We here aimed to systematically investigate the association between
the ChOLE classification and (i) hearing, (ii) recidivism rate, and (iii) postoperative complications. These
data may increase the utility of the ChOLE classification in clinical practice and research by stratifying
patients according to expected outcomes or risks for complications. Methods: In this prospective mul-
ticentric study, we included adult patients undergoing tympanomastoid surgery due to cholesteatoma.
Main outcome measures included the association of the ChOLE classification system with (i) audiomet-
ric data including air conduction (AC) and bone conduction (BC) pure-tone average (PTA), and the
air-bone gap (ABG), (ii) recidivism and complication. Results: A total of 160 patients suffering from
cholesteatoma were included. ChOLE stage distribution was stage I in 23 (14%), stage II in 128 (80%),
and stage III in 9 (6%) patients. The ChOLE stage was associated with the postoperative AC PTA
(p = 0.05) and the postoperative BC PTA (p = 0.02). Further, the status of the ossicular chain after
surgery (ChOLE subdivision ”O”) was associated with both the postoperative ABG (p = 0.0001) and the
postoperative AC PTA (p = 0.003). Moreover, we found an association between complications (ChOLE
subdivision ”L) and both the postoperative BC PTA (p = 0.04) and the postoperative ABG (p = 0.04).
No association between the ChOLE stage was found to both cholesteatoma recidivism and surgical com-
plications. Conclusion: The ChOLE classification is a new system to classify cholesteatomas. We provide
evidence that hearing outcomes vary among different ChOLE stages. In particular, hearing outcomes
are associated with the ChOLE subdivision ”O” and ”L”. Thus, the ChOLE classification system has a
predictive value regarding hearing outcomes.
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Abstract
Purpose To establish a standardized reporting system of cholesteatoma, the ChOLE classification has recently been intro-
duced. We here aimed to systematically investigate the association between the ChOLE classification and (i) hearing, (ii) 
recidivism rate, and (iii) postoperative complications. These data may increase the utility of the ChOLE classification in 
clinical practice and research by stratifying patients according to expected outcomes or risks for complications.
Methods In this prospective multicentric study, we included adult patients undergoing tympanomastoid surgery due to 
cholesteatoma. Main outcome measures included the association of the ChOLE classification system with (i) audiometric 
data including air conduction (AC) and bone conduction (BC) pure-tone average (PTA), and the air–bone gap (ABG), (ii) 
recidivism and complication.
Results A total of 160 patients suffering from cholesteatoma were included. ChOLE stage distribution was stage I in 23 
(14%), stage II in 128 (80%), and stage III in 9 (6%) patients. The ChOLE stage was associated with the postoperative AC 
PTA (p = 0.05) and the postoperative BC PTA (p = 0.02). Further, the status of the ossicular chain after surgery (ChOLE 
subdivision “O”) was associated with both the postoperative ABG (p = 0.0001) and the postoperative AC PTA (p = 0.003). 
Moreover, we found an association between complications (ChOLE subdivision “L) and both the postoperative BC PTA 
(p = 0.04) and the postoperative ABG (p = 0.04). No association between the ChOLE stage was found to both cholesteatoma 
recidivism and surgical complications.
Conclusion The ChOLE classification is a new system to classify cholesteatomas. We provide evidence that hearing outcomes 
vary among different ChOLE stages. In particular, hearing outcomes are associated with the ChOLE subdivision “O” and 
“L”. Thus, the ChOLE classification system has a predictive value regarding hearing outcomes.
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Introduction
Otitis media chronica cholesteatomatosa (OMCC) is a 
chronic inflammation of the middle ear with formation of 
cholesteatoma. By definition, cholesteatoma is an epider-
moid spreading of keratinizing squamous epithelium of 
the outer tympanic membrane into the middle ear cavity 
[1]. This process results in a chronic inflammation leading 
to destruction of middle ear structures and the surround-
ing bone. Cholesteatomas are divided into congenital and 
aquired cholesteatoma [2]. Congenital cholesteatoma is a 
congenital displacement of squamous epithelium during the 
embryonal phase, while acquired cholesteatoma describes 
invasion of keratinizing squamous epithelium from the 
external auditory canal or the tympanic membrane into the 
middle ear after birth. Despite being a common otologic 
diagnosis, there are still large differences in the definition, 
classifications and management of cholesteatomas [3]. Yet, 
standardized reporting of cholesteatoma characteristics and 
surgical outcomes is a prerequisite for comparison of surgi-
cal techniques and outcomes among centers in an interna-
tional setting.
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To establish a standardized reporting system of chole-
steatoma, there have been several attempts to categorize and 
classify cholesteatoma using general classifications as devel-
oped by the European Academy of Otology and Neurotology 
(EAONO) or the Japanese Otological Society (JOS). These 
two societies eventually published the “EAONO/JOS Joint 
Consensus Statements on the Definitions, Classification a 
Staging of Middle Ear Cholesteatoma” in 2016 [4]. Yet, the 
EAONO/JOS joint consensus has several shortcomings, as 
previously pointed out [5]. The EAONO/JOS joint consen-
sus classification is primarily based on cholesteatoma exten-
sion and complications. However, apical or supra/infralaby-
rinthine cholesteatomas cannot be classified, and the status 
of the ossicular chain as well as the degree of mastoid pneu-
matization and ventilation is not included [4]. In an attempt 
to overcome these drawbacks, the ChOLE classification has 
been developed [5]. The ChOLE classification is based on 
cholesteatoma extension, ossicular chain status (as partially 
adopted form classification by Kartush [6] and Fisch [2]), 
complications as well as degree of mastoid pneumatization 
and ventilation. A numeric rule is used for staging, whereby 
stages range from stage I to stage III.
In a small cohort (n = 24), preliminary evidence has been 
found that hearing outcomes in cholesteatoma surgery are 
associated with the ChOLE classification [5]. In particular, 
the ossicular chain status (O) tended to correlate with the 
pre- and postoperative air–bone gap (ABG). However, no 
study has systematically investigated the association of hear-
ing and the ChOLE classification up to date. Further, there 
are no data on the relationship of the ChOLE classification 
and both recidivism rate and postoperative complications. 
These data may increase the utility of the ChOLE classifica-
tion in clinical practice and research by stratifying patients 
according to expected outcomes or risks for complications. 
Therefore, in the present study, we aimed to investigate the 
relationship between the ChOLE classification system and 




The study protocol was approved by the local Ethics Com-
mittees in accordance with the Helsinki declaration and its 
amendments (No. 2016-02216, Kantonale Ethikkommission, 
Zurich, Switzerland; No. A2017-0101, Rostock, Germany). 
Informed consent was obtained from all the participants.
Patients
Patients were consecutively recruited from two tertiary 
referral centers between January 2016 and November 2018. 
Inclusion criteria were a clinical diagnosis of cholesteatoma 
and a minimum age of 18 years. Patients underwent extirpa-
tion of the cholesteatoma via a retroauricular access includ-
ing a mastoidectomy and tympanoplasty. Autologous recon-
struction material (local pediculed muscle flaps, bone paté, 
temporal muscle fascia and cartilage) was used to obliterate 
the open mastoid cavity and/or to reconstruct the posterior 
canal wall. In some patients, ossicular chain reconstruc-
tion (OCR, i.e., ossiculoplasty [2]) was performed during 
primary surgery. If the malleus (with or without head) and 
stapes were present, OCR was performed using autologous 
or titanium incus interposition. In the other cases, a titanium 
partial or total ossicular replacement prosthesis was used for 
OCR, depending on the individual ossicular defect.
Clinical data collection
From the clinical record, demographic data were extracted. 
Complications refer to complications occurring up to one 
year after surgery. Complications include new tinnitus or 
vertigo, facial paralysis, liquorrhoe, infection, stenosis of the 
external auditory canal, perforation of the tympanic mem-
brane, and severe postoperative otalgia. Recidivism was 
defined as clinically diagnosed reoccurrence of cholestea-
toma at the same or a different location within one year [7].
Pure‑tone audiometry
Pure-tone audiometry was performed following stand-
ard procedures in accordance with ISO 8253-1 during the 
routine preoperative visit and at the postoperative visit 
6–12 months after surgery. Pure-tone average (PTA) was 
calculated from the hearing threshold levels at 0.5, 1, 2 and 
4 kHz. The ABG refers to the difference between air con-
duction (AC) PTA and bone conduction (BC) PTA. The BC 
PTA was set to 120 dB if the patient did not detect any tone 
in all the tested frequencies. The difference between the pre- 
and postoperative measurement is referred to as “shift”.
ChOLE classification
Cholesteatomas were classified and staged according to 
the recently introduced ChOLE classification [5]. Briefly, 
cholesteatomas are classified by (i) extension with subdi-
visions Ch1 describing very limited extension within the 
middle ear to Ch4 describing a petrous apex cholesteatoma 
and (ii) the status of the ossicular chain with O0 indicating 
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an intact ossicular chain to O4 indicating an ossicular 
defect with fixed stapes only. Of note, the O subdivision 
describes the status of the ossicular chain after extirpation 
of the cholesteatoma, but before OCR. Cholesteatomas are 
further classified by (iii) complications with L2 describing 
extracranial and L4 describing intracranial complications, 
and (iv) Eustachian tube functions as determined by the 
degree of mastoid pneumatization and ventilation with E0 
indicating a good to E2 indicating a poor pneumatization 
and ventilation. After determining the ChOLE subdivisions, 
staging into three different stages (I–III) is performed using 
a numeric rule. The ChOLE classification was determined 
based on intraoperative findings (subdivisions Ch, O and 
L) and preoperative CT imaging (subdivision E) using a 
freely available online software tool [8]. Of note, subdivi-
sion L refers to complications of the cholesteatoma itself 
as assessed intraoperatively, while specific complications 
mentioned in the subsection “Clinical data collection” above 
refer to postoperative complications occurring within one 
year after surgery.
Statistical analysis
All statistical tests were selected before data collection. 
Cholesteatoma recidivism was compared to ChOLE stage, 
cholesteatoma extension (Ch) and mastoid pneumatization/
ventilation (E). Further, ChOLE stage, cholesteatoma exten-
sion (Ch), the status of the ossicular chain (O) and com-
plications (L) were compared with each the postoperative 
AC PTA, postoperative BC PTA and postoperative ABG. 
The ChOLE stage was compared to the AC PTA shift and 
BC PTA shift. Complications were compared to the ChOLE 
stage and each of the four ChOLE subdivisions.
Statistical analyses were performed using RStudio 
(version 1.2.1335) [9]. The significance level was set to 
p < 0.05. To analyze whether cholesteatoma recidivism is 
more common in larger cholesteatomas or poor pneuma-
tization/ventilation of the mastoid, Fisher’s test was used. 
A Kruskal–Wallis test was used to assess the relationship 
between the ChOLE classification and the hearing outcomes. 
If a statistically significant difference among the groups was 
found, post hoc testing including Dunn’s test to correct for 
multiple comparison was carried out. If not otherwise speci-
fied, values are reported as absolute number and percentage, 
mean with SD or median with the 10th and 90th percentile.
Results
A total number of 166 patients were recruited, of which six 
patients were excluded because of missing values for the 
subdivision of the ChOLE classification or missing follow-
up. Therefore, data from 160 patients were included in 
the final analysis. From 160 patients with cholesteatoma, 
69 (43%) were female and 91 were male (57%). The mean 
age was 38.7 years (SD 18.8). In 87 patients (54%), the left 
ear was affected, in the remaining 73 patients (46%), the 
right ear was affected. OCR at the primary surgery was 
performed in 22 (14%) patients. Cholesteatoma recidivism 
was diagnosed in 16 patients (10%). Regarding complica-
tions, new tinnitus and new vertigo each were observed in 
19 (12%) patients. A transient facial paralysis and postop-
erative leak of cerebrospinal fluid each were observed in 1 
(0.6%) patient. Surgical site infections occurred in 23 (14%) 
patients and severe postoperative otalgia was found in 9 (6%) 
patients. Postoperatively, a (re-)perforation of the tympanic 
membrane occurred in 5 (3%) patients and external auditory 
canal stenosis developed in 15 (9%) patients.
Audiometric outcomes
Due to missing audiometric data in five patients, analyses 
involving audiometric data were carried out in 155 patients. 
Audiometry was performed at a mean follow-up time of 9.7 
(SD 2.9) months. The median preoperative AC PTA was 
45.0 dB HL (10th–90th percentile: 23.8–68.8 dB HL). The 
median preoperative BC PTA was 15.0 dB HL (10th–90th 
percentile: 2.5–39.5 dB HL). The median preoperative ABG 
was 26.3 dB (10th–90th percentile: 11.3–43.8 dB). Postop-
eratively, the median AC PTA and BC PTA were 46.3 dB 
HL (10th–90th percentile: 26.3–80.0 dB HL), and 15.0 dB 
HL (10th–90th percentile: 3.8–43.8 dB HL), respectively. 
The median ABG for the postoperative hearing was 30.0 dB 
(10th–90th percentile: 13.8–47.0 dB). One patient became 
deaf after surgery. In this case, a ChOLE stage III chole-
steatoma (Ch4a O1 L2 E2) with infra- and intralabyrinthine 
extension was diagnosed.
ChOLE classification
ChOLE stage I cholesteatoma was found in 23 (14%), 
ChOLE stage II cholesteatoma was found in 128 (80%), 
and ChOLE stage III cholesteatoma was found in 9 (6%) 
patients. Regarding cholesteatoma extension (Ch), Ch1 was 
found in 42 (26%), Ch2 in 71 (44%), Ch3 in 37 (23%) and 
Ch4 in 10 (7%) of the patients. Assessing the status of the 
ossicular chain at the end of surgery (O), O0 was found in 
17 (11%), O1 in 97 (61%), O2 in 36 (23%), O3 in 7 (3%) and 
O4 in 3 (2%) of the patients. Classifying complications (L), 
L0 was found in 149 (93%), L2 in 11 (7%) and L4 in none 
of the patients (note that there is no L1 and no L3 subdivi-
sion). Assessing eustachian tube function as determined by 
the degree of mastoid pneumatization and ventilation (E), 
E0 was found in 24 (15%), E1 in in 75 (47%), E2 in 61 (38%) 
of the patients.
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Association of cholesteatoma recidivism 
and the ChOLE classification
To analyze whether cholesteatoma recidivism is more com-
mon in larger cholesteatomas and poor pneumatization/ven-
tilation of the mastoid, recidivism rates were compared to 
the ChOLE stage and the divisions Ch and E. No association 
was found between the recidivism rate and (i) the ChOLE 
stage (p = 0.33, Fig. 1a), (ii) the cholesteatoma extension 
(Ch) (p = 0.39, Fig. 1b), and (iii) the degree of pneumatiza-
tion and ventilation of the mastoid bone (p = 0.9, Fig. 1c).
Association of the postoperative hearing 
and the ChOLE classification
The postoperative AC PTA showed a trend towards increas-
ing thresholds with increasing ChOLE stage (p = 0.05, 
Fig. 2a). No association was found between the postopera-
tive AC PTA and the extension of the cholesteatoma (Ch) 
(p = 0.63, Fig. 2b). In contrast, the status of the ossicular 
chain after the surgery (O) was strongly associated with the 
postoperative AC PTA (p = 0.003, Fig. 2c). In particular, 
we observed a trend of an increased postoperative AC PTA 
with increasing O status, while post hoc testing revealed 
a statistically significant difference between status O0 and 
O3 (p = 0.04). This effect could still be observed in a post 
hoc analysis grouping patients according to whether primary 
OCR was performed or not (Fig. 2d). Yet, within the indi-
vidual O subdivisions, this post hoc analysis revealed no 
differences between patients who underwent primary OCR 
and those who did not.
The postoperative BC PTA was associated with the 
ChOLE stage (p = 0.02). In particular, post hoc testing 
revealed that the postoperative BC PTA is significantly 
different between ChOLE stage I vs. III (p = 0.01) and 
II vs. III (p = 0.04, Fig. 2e). The postoperative BC PTA 
was neither associated with the cholesteatoma extension 
(Ch) (p = 0.06, Fig. 2f) nor the ossicular chain status (O) 
(p = 0.17, Fig. 2g, h). Further, we found an association 
between the ChOLE subdivision covering complica-
tions (L) and the postoperative BC PTA. Patients clas-
sified as L0 had a lower median postoperative BC PTA 
than patients classified as L2 (median difference 14.4 dB, 
p = 0.04).
The postoperative ABG was overall significantly differ-
ent among the ChOLE stages (p = 0.04) with post hoc com-
parison revealing no significant differences between any two 
groups (Fig. 2i). The postoperative ABG was not associated 
with cholesteatoma extension (Ch) (p = 0.06, Fig. 2j), but 
strongly associated with the status of the ossicular chain 
after surgery (O) (p = 0.0001, Fig. 2k). For the latter compar-
ison, significant differences in the postoperative ABG were 
revealed between ossicular chain status O0 vs. O2 (p = 0.01) 
and O0 vs. O3 (p = 0.02). When grouping patients according 
to whether primary OCR was performed or not, the latter 
effect could still be observed among patients that did not 
undergo primary OCR (Fig. 2l). However, within subdivi-
sions O1 and O2, patients who underwent primary OCR had 
a significantly smaller median ABG than patients who did 
not (p = 0.0007 within O1, p = 0.01 within O2).
Lastly, we found an association between the ChOLE 
subdivision covering complications (L) and the postopera-
tive ABG. Patients classified as L0 had a smaller median 
postoperative ABG than patients classified as L2 (median 
difference 10.0 dB, p = 0.04).
Association of hearing changes and ChOLE stage
There was no association between the ChOLE stage and the 
difference of pre- and postoperative hearing (AC PTA shift; 
p = 0.14, Fig. 3a). In contrast, the ChOLE stage showed a 
significant association with the difference of the pre- and 
postoperative BC PTA (BC PTA shift; p = 0.03, Fig. 3b).
Fig. 1  a–c Relationship of the ChOLE classification and cholestea-
toma recurrence. Cholesteatoma recurrence was compared to the 
ChOLE stage (a), extension of cholesteatoma (ChOLE subdivision 
Ch; b), and the degree of pneumatization and ventilation of the mas-
toid bone (ChOLE subdivision E; c). Percentages refer to percentage 
of patients experiencing cholesteatoma recurrence
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Fig. 2  Association of audiometric outcomes and the ChOLE stage 
as well as the ChOLE subdivisions Ch and O. a–d Postoperative air-
conduction pure-tone average compared to the ChOLE stage (a) and 
the ChOLE subdivisions Ch (b) and O (c, d). Regarding subdivision 
O, a post-hoc analysis was performed grouping patients according 
to whether primary ossicular chain reconstruction (OCR) was per-
formed (“ + OCR”) or not (d). This applies also to subfigure h and 
l. e–h Postoperative bone-conduction pure-tone average compared 
to the ChOLE stage (e) and the ChOLE subdivisions Ch (f) and O 
(g, h). i–l Postoperative air–bone gap compared to the ChOLE stage 
(i) and the ChOLE subdivisions Ch (j) and O (k, l). Note that two 
deaf patients are included in all subfigures, which are represented by 
an air- and bone-conduction of 120 dB resulting in an ABG of 0 dB. 
Bars represent median, error bars indicate interquartile range. Groups 
with n < 5 were excluded from statistical analyses. In subfigures 2d, 
2  h and 2  l, comparisons were only performed among non-recon-
structed (O0, O1, O2, O3, O4) and among reconstructed (O1 + OCR, 
O2 + OCR, O3 + OCR, O4 + OCR) ears
Fig. 3  a–b Shift in air-conduc-
tion (a) and bone-conduction 
(b) in association to the ChOLE 
stage. Bars represent median, 
error bars indicate interquartile 
range. In (b), the black dot indi-
cates audiometric data of one 
patient with a cholesteatoma 
exhibiting intralabyrinthine 
extension who became deaf 
after surgery
 European Archives of Oto-Rhino-Laryngology
1 3
Association of the sum of complications 
and the ChOLE classification
A higher ChOLE stage was not associated with a higher 
number of complications (p = 0.42) or a higher value in the 
ChOLE subdivision Ch (p = 0.66), O (p = 0.86), L (p = 0.13) 
or E (p = 0.93).
Discussion
This is the first study investigating hearing outcomes and 
complication rates of surgical treatment of cholesteatoma 
based on the ChOLE classification, a standardized staging 
and classification system for cholesteatoma surgery. The 
most significant results were the association of the ChOLE 
stage with both the postoperative AC and BC PTA. Further, 
the ossicular chain after surgery (ChOLE subdivision O) was 
strongly associated with both the postoperative ABG and the 
postoperative AC PTA.
Several studies over the last decades reported factors 
affecting hearing outcomes of tympanomastoid surgery for 
cholesteatoma [10–13]. In conclusion, most prominently, a 
preserved stapes suprastructure predicts a favorable hear-
ing outcome. In contrast, large perforations, otorrhea and 
an absent malleus handle predict an unfavorable hearing 
outcome. These findings highlight the importance of the 
ossicular chain regarding the postoperative hearing out-
come. In accordance, we found that the ChOLE subdivision 
O describing the ossicular status after surgery was strongly 
associated with both the postoperative ABG and the post-
operative AC PTA. In a preliminary analysis on 24 patients, 
Linder et al. reported a trend towards a larger ABG with 
increasing O subdivision of the ChOLE score [5]. We could 
confirm this finding in our cohort and show statistically sig-
nificant differences between O0 vs. O2 as well as O0 vs. 
O3. Also, Linder et al. reported an ABG closure < 20 dB in 
all of the patients exhibiting a O0 status while this rate was 
lower in patients exhibiting O1, O2 or O3 [5]. In accordance, 
we found a median postoperative ABG of less than 20 dB 
in patients exhibiting an intact ossicular chain (subdivision 
O0), while an ossicular defect classified as O1-O4 was asso-
ciated with a postoperative median ABG around 40 dB, if no 
OCR was performed. However, primary OCR in ossicular 
chain defects classified as O1 and O2 resulted in a median 
postoperative ABG below 20 dB, which is comparable to the 
postoperative ABG in patients with an intact ossicular chain.
Recently, prognostic factors for short-term hearing out-
comes of ossicular chain reconstruction for “pars flaccida 
cholesteatoma” as classified by the EAONO/JOS staging 
system have been reported [14]. The rate of successful 
hearing improvement significantly decreased with increase 
in EAONO/JOS stage. Hearing outcomes were favorable 
if the stapes was not involved in the disease process. This 
corresponds well to our finding of significantly different 
postoperative ABG in ossicular chain statuses O0 (intact 
ossicular chain) vs. O2 (malleus and footplate only) as 
well as O0 vs. O3 (mobile footplate only).
No association was found between the recidivism rate 
and (i) the ChOLE stage, (ii) the degree of cholesteatoma 
extension or (iii) a lower degree of pneumatization. We 
are not aware of any studies systematically investigat-
ing the effect of cholesteatoma extension and the degree 
of mastoid pneumatization on residual cholesteatoma or 
cholesteatoma recidivism. Our findings may simply indi-
cate that cholesteatomas, regardless of the ChOLE stage, 
underwent adequate surgical treatment. This may be fur-
ther corroborated by the observation that no association 
between either the ChOLE stage or the ChOLE subdivi-
sions was found to both cholesteatoma recidivism and 
complications. However, we hypothesize that these analy-
ses may be biased by the fact that cholesteatoma extension 
and the degree of mastoid pneumatization itself guide the 
type of surgical approach and technique [2], which may 
act as a confounder. Moreover, since it was not the aim 
of this study to compare surgical techniques, the study 
lacks the statistical power for such a comparison. This 
issue should be addressed in a larger patient cohort with 
a longer follow-up.
Our study has several limitations. First, we observed a 
relatively high proportion of ChOLE stage II cholesteato-
mas. We speculate that this is due to the low barrier access 
to health care in our developed countries, where extensive 
cholesteatomas and cholesteatoma complications show a 
decreasing incidence in contrast to developing countries [15, 
16]. Second, only a small proportion of supra-/infralabyrin-
thine and petrous apex cholesteatomas (ChOLE subdivision 
Ch4) was observed in our cohort, which hampers the power 
of the statistical analyses concerning Ch4. Yet, the observed 
distribution may reflect that supra-/infralabyrinthine and 
petrous apex cholesteatomas are a fairly small proportion 
of all cholesteatomas [17, 18]. Lastly, the follow-up period 
of one year may only cover a part of cholesteatoma recidi-
vism [19]. Therefore, the finding of no association between 
cholesteatoma recidivism and neither the ChOLE stage nor 
the ChOLE subdivisions should be interpreted with caution.
In conclusion, the ChOLE classification is a new system 
to categorize cholesteatoma. This classification aims at gen-
erating comparable data sets regarding surgical outcomes. In 
this study, we provide evidence that hearing outcomes vary 
among different ChOLE stages. In particular, hearing out-
comes are both associated with the ChOLE subdivision “O” 
and “L”. Thus, the ChOLE classification system has a pre-
dictive value regarding hearing outcomes. Future work will 
also investigate the association of the ChOLE classification 
to subjective outcomes [20]. We further encourage using the 
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ChOLE classification with the aim of standardizing outcome 
research in cholesteatoma surgery by generating comparable 
data sets.
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